News

Archive: March, 2022

DoD Awards Contract Modifications to Purchase COVID-19 Antigen Over-the-Counter Test Kits in Support of POTUS’ One Billion Free At-Home COVID-19 Tests
March 28, 2022 — In the month of March, the Department of Defense (DoD), in coordination with the U.S. Department of Health and Human Services (HHS), awarded contract modifications to Abbott Rapid Dx North America, LLC (Orlando, Florida) and iHealth Labs Inc. (Sunnyvale, California), purchasing an additional 176.8 million over-the-counter COVID-19 test kits. The DoD’s Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) led this effort in partnership with DoD’s Defense Assisted Acquisition Cell (DA2), Army Contracting Command, and the HHS Office of the Assistant Secretary for Preparedness and Response (ASPR). The procurement was funded through the American Rescue Plan Act to supply critical medical resources to the nation... MORE

Two uniformed service members are in a tent. One wears PPE and a faceshield, while they use a nasal swab to collect a COVID-19 sample from the other Service member in uniform.

DOD-Supported 10mg Naloxone Autoinjector Receives FDA Approval to Treat Known or Potential Ultra-Potent Opioid Exposure
March 17, 2022 — On February 28, 2022, the FDA approved a 10mg naloxone autoinjector designed for non-medically trained users to protect service members against ultra-potent opioids. It was developed by Kaléo, Inc., in collaboration with the JPM CBRN Medical and the Chemical and Biological Defense Program. The JPM CBRN Medical’s Rapid Opioid Countermeasure System (ROCS) program has spent nearly three years developing the 10mg naloxone autoinjector as a rescue treatment to counter pharmaceutical-based agents, which are highly lethal at very low doses. The product is specifically indicated for military and chemical incident responders, and can also be used before suspected opioid exposure. ... MORE

While wearing MOPP Level 4 gear a test player prepares to use a ROCS auto-injector on a simulated causality.

News Search

News Archive - Search by Year and Month

JPEO-CBRND Press Kit

Download our press kit, which includes helpful documents to better understand our work, such as – Command Brief, Chemical Biological Defense Program's Enterprise strategy, the JPEO-CBRND's Capabilities Catalog, Leadership Biographies, COVID-19 fact sheets, and contracting overview documents.

JPEO-CBRND Public Affairs Office

The JPEO-CBRND Public Affairs Office coordinates and responds to all public affairs and media relations needs on behalf of the JPEO-CBRND. To request a speaker, subject matter expert, or for other interview or request for comment please email our Public Affairs Office email below.